InvestorsHub Logo
Followers 298
Posts 19977
Boards Moderated 2
Alias Born 05/05/2014

Re: None

Wednesday, 04/14/2021 4:06:26 PM

Wednesday, April 14, 2021 4:06:26 PM

Post# of 327
FUAPF 's press release is gigantic and there's much more to come. FUAPF is a 50x (50fold as in each $1K could turn into $50,000) company within a couple of years or so (from $0.19 to over $10+), IMO, ... maybe even more due to enormous high-margin revenue model and only "game" of this magnitude in town.

https://www.globenewswire.com/news-release/2021/04/13/2209024/0/en/GCAC-Closes-Largest-Revenue-Deal-for-its-Efixii-Seed-to-Seed-Platform-with-Malta-Based-Medical-Cannabis-Cultivator.html?fbclid=IwAR0Lz1Wi4g6RMVk7VhJmdfjX703FJ-Y9oJteJcJ8789aVoem3qyW7rl0LCU

Highlights from yesterday's press release:
- Alone in 2022 the cultivator Herb will grow 44 million grams of medical cannabis.
- This translates to $8.8 million in SaaS licensing fees and $7.9 million in data sales for a total of $16.7 million.
- Herb's output grows to 66 million grams in 2023 and beyond, equaling $25 million per year at a huge 65% margin.
- For 2022, FUAPF's grams under contract goal (aka SaaS licensing) is 94 million (!).
- It's early Q2/2021 and FUAPF closed half of next year's business already.
- Herb is unique because they can generate 10x more plants per square meter.